• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环糊精与氨基酸联合用于开发儿童用头孢克肟口服溶液

Combined Use of Cyclodextrins and Amino Acids for the Development of Cefixime Oral Solutions for Pediatric Use.

作者信息

Cirri Marzia, Mennini Natascia, Nerli Giulia, Rubia Jessica, Casalone Enrico, Melani Fabrizio, Maestrelli Francesca, Mura Paola

机构信息

Department of Chemistry, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.

Department of Biology, University of Florence, Via Madonna del Piano 6, 50019 Sesto Fiorentino, Italy.

出版信息

Pharmaceutics. 2021 Nov 13;13(11):1923. doi: 10.3390/pharmaceutics13111923.

DOI:10.3390/pharmaceutics13111923
PMID:34834338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8620304/
Abstract

Cefixime (CEF) is a cephalosporin included in the WHO Model List of Essential Medicines for Children. Liquid formulations are considered the best choice for pediatric use, due to their great ease of administration and dose-adaptability. Owing to its very low aqueous solubility and poor stability, CEF is only available as a powder for oral suspensions, which can lead to reduced compliance by children, due to its unpleasant texture and taste, and possible non-homogeneous dosage. The aim of this work was to develop an oral pediatric CEF solution endowed with good palatability, exploiting the solubilizing and taste-masking properties of cyclodextrins (CDs), joined to the use of amino acids as an auxiliary third component. Solubility studies indicated sulfobutylether-β-cyclodextrin (SBEβCD) and Histidine (His) as the most effective CD and amino acid, respectively, even though no synergistic effect on drug solubility improvement by their combined use was found. Molecular Dynamic and H-NMR studies provided insight into the interactions of binary CEF:His and ternary CEF:His:SBEβCD systems used to prepare CEF solutions, which resulted stable and maintained unchanged antimicrobial activity during the two-weeks-use in therapy. The ternary solution was superior in terms of more tolerable pH (5.6 vs. 4.7) and better palatability, being resulted completely odorless by a panel test.

摘要

头孢克肟(CEF)是世界卫生组织儿童基本药物示范清单中包含的一种头孢菌素。液体制剂被认为是儿科用药的最佳选择,因为其易于给药且剂量适应性强。由于CEF的水溶性极低且稳定性差,它仅以口服混悬剂粉末形式提供,这可能会导致儿童依从性降低,因为其质地和味道不佳,且可能存在剂量不均匀的情况。这项工作的目的是开发一种具有良好适口性的儿科口服CEF溶液,利用环糊精(CDs)的增溶和掩味特性,并结合使用氨基酸作为辅助第三成分。溶解度研究表明,磺丁基醚-β-环糊精(SBEβCD)和组氨酸(His)分别是最有效的CD和氨基酸,尽管未发现它们联合使用对提高药物溶解度有协同作用。分子动力学和H-NMR研究深入了解了用于制备CEF溶液的二元CEF:His和三元CEF:His:SBEβCD系统的相互作用,该溶液在治疗两周使用期间稳定且抗菌活性保持不变。三元溶液在更可耐受的pH值(5.6对4.7)和更好的适口性方面更具优势,经小组测试结果完全无味。

相似文献

1
Combined Use of Cyclodextrins and Amino Acids for the Development of Cefixime Oral Solutions for Pediatric Use.环糊精与氨基酸联合用于开发儿童用头孢克肟口服溶液
Pharmaceutics. 2021 Nov 13;13(11):1923. doi: 10.3390/pharmaceutics13111923.
2
Development of a stable oral pediatric solution of hydrochlorothiazide by the combined use of cyclodextrins and hydrophilic polymers.通过环糊精和亲水性聚合物的联合使用开发稳定的口服小儿氢氯噻嗪溶液。
Int J Pharm. 2020 Sep 25;587:119692. doi: 10.1016/j.ijpharm.2020.119692. Epub 2020 Jul 24.
3
Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state.二元和三元环糊精与硝酸益康唑在溶液和固态中的比较分析。
J Pharm Biomed Anal. 2014 Mar;91:81-91. doi: 10.1016/j.jpba.2013.12.029. Epub 2014 Jan 2.
4
Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.二氢青蒿素与羟丙基-β-环糊精和卵磷脂的三元体系:同时提高药物在水溶液中的溶解度和稳定性。
J Pharm Biomed Anal. 2013 Sep;83:141-8. doi: 10.1016/j.jpba.2013.05.001. Epub 2013 May 13.
5
The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state.溶液和固态中二聚和三聚磺丁基醚-β-环糊精与积雪草苷包合物的研究。
Carbohydr Res. 2020 Dec;498:108190. doi: 10.1016/j.carres.2020.108190. Epub 2020 Oct 28.
6
Physicochemical and molecular modeling studies of cefixime-L-arginine-cyclodextrin ternary inclusion compounds.塞呋肟酸-L-精氨酸-环糊精三元包合物的理化性质和分子建模研究。
Carbohydr Polym. 2013 Nov 6;98(2):1317-25. doi: 10.1016/j.carbpol.2013.07.070. Epub 2013 Aug 3.
7
Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics.磺丁基醚-β-环糊精/壳聚糖纳米粒和微粒及其物理化学特性
Int J Pharm. 2014 Sep 10;472(1-2):282-7. doi: 10.1016/j.ijpharm.2014.06.039. Epub 2014 Jun 24.
8
Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes.长春西汀-磺丁基醚-β-环糊精二元和三元复合物的研究及物理化学表征
Chem Pharm Bull (Tokyo). 2003 Aug;51(8):914-22. doi: 10.1248/cpb.51.914.
9
Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.羟丙基-β-环糊精对头孢地尼的增溶作用。
Drug Dev Ind Pharm. 2013 Nov;39(11):1638-43. doi: 10.3109/03639045.2012.728231.
10
Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.将一种难溶于水的药物制成适合儿科患者的口服溶液;以劳拉西泮作为模型药物。
Eur J Pharm Sci. 2017 Mar 30;100:205-210. doi: 10.1016/j.ejps.2017.01.025. Epub 2017 Jan 23.

引用本文的文献

1
Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics.环糊精:提升现代治疗药物的递送、溶解度及生物利用度。
Pharmaceutics. 2025 Feb 22;17(3):288. doi: 10.3390/pharmaceutics17030288.
2
Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use.优化用于儿科的卡维地洛口服溶液制剂的适口性和稳定性研究。
Pharmaceutics. 2023 Dec 25;16(1):30. doi: 10.3390/pharmaceutics16010030.
3
Investigation of the Affinity of Ceftobiprole for Selected Cyclodextrins Using Molecular Dynamics Simulations and HPLC.

本文引用的文献

1
Cyclodextrin Multicomponent Complexes: Pharmaceutical Applications.环糊精多组分复合物:药物应用
Pharmaceutics. 2021 Jul 20;13(7):1099. doi: 10.3390/pharmaceutics13071099.
2
Development and characterization of orodispersible film containing cefixime trihydrate.含头孢克肟三水合物的口腔分散片的研制与评价。
Drug Dev Ind Pharm. 2020 Dec;46(12):2070-2080. doi: 10.1080/03639045.2020.1843477. Epub 2020 Nov 6.
3
Development of a stable oral pediatric solution of hydrochlorothiazide by the combined use of cyclodextrins and hydrophilic polymers.
采用分子动力学模拟和 HPLC 研究头孢托罗与选定的环糊精的亲和力。
Int J Mol Sci. 2023 Nov 23;24(23):16644. doi: 10.3390/ijms242316644.
4
Review of Applications of Cyclodextrins as Taste-Masking Excipients for Pharmaceutical Purposes.环糊精作为掩味药用辅料的应用综述。
Molecules. 2023 Oct 7;28(19):6964. doi: 10.3390/molecules28196964.
5
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use.纳米结构脂质载体与壳聚糖纳米粒作为难溶性药物载体用于开发适合儿科使用的口服液体制剂的设计、评价与比较
Pharmaceutics. 2023 Apr 21;15(4):1305. doi: 10.3390/pharmaceutics15041305.
6
An Overview of Taste-Masking Technologies: Approaches, Application, and Assessment Methods.掩味技术概述:方法、应用和评估方法。
AAPS PharmSciTech. 2023 Feb 14;24(2):67. doi: 10.1208/s12249-023-02520-z.
7
Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.环糊精与抗生素及抗菌剂形成的包合物作为药物递送系统——药学视角
Pharmaceutics. 2022 Jun 30;14(7):1389. doi: 10.3390/pharmaceutics14071389.
通过环糊精和亲水性聚合物的联合使用开发稳定的口服小儿氢氯噻嗪溶液。
Int J Pharm. 2020 Sep 25;587:119692. doi: 10.1016/j.ijpharm.2020.119692. Epub 2020 Jul 24.
4
A Comparative Solubility Enhancement Study of Cefixime Trihydrate Using Different Dispersion Techniques.采用不同分散技术的头孢克肟三水合物增溶比较研究。
AAPS PharmSciTech. 2019 May 22;20(5):194. doi: 10.1208/s12249-019-1395-y.
5
Cyclodextrins: structure, physicochemical properties and pharmaceutical applications.环糊精:结构、物理化学性质及药物应用。
Int J Pharm. 2018 Jan 15;535(1-2):272-284. doi: 10.1016/j.ijpharm.2017.11.018. Epub 2017 Nov 11.
6
Use of Adult Sensory Panel to Study Individual Differences in the Palatability of a Pediatric HIV Treatment Drug.使用成人感官小组研究儿科艾滋病毒治疗药物适口性的个体差异。
Clin Ther. 2017 Oct;39(10):2038-2048. doi: 10.1016/j.clinthera.2017.08.012. Epub 2017 Sep 18.
7
Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.将一种难溶于水的药物制成适合儿科患者的口服溶液;以劳拉西泮作为模型药物。
Eur J Pharm Sci. 2017 Mar 30;100:205-210. doi: 10.1016/j.ejps.2017.01.025. Epub 2017 Jan 23.
8
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and l-arginine aimed to improve the drug solubility.对恶丙嗪与随机甲基化-β-环糊精和L-精氨酸三元体系的物理化学性质进行分析,旨在提高药物溶解度。
J Pharm Biomed Anal. 2016 Sep 10;129:350-358. doi: 10.1016/j.jpba.2016.07.024. Epub 2016 Jul 18.
9
Design and stability study of an oral solution of amlodipine besylate for pediatric patients.小儿苯磺酸氨氯地平口服溶液的设计与稳定性研究
Eur J Pharm Sci. 2016 Sep 20;92:220-3. doi: 10.1016/j.ejps.2016.05.019. Epub 2016 May 20.
10
Development of a taste-masked orodispersible film containing dimenhydrinate.研制一种含有茶苯海明的掩味口腔速崩片。
Pharmaceutics. 2012 Oct 26;4(4):551-62. doi: 10.3390/pharmaceutics4040551.